Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T18:21:18.133Z.
Calculation as of: 2026-10-06T18:21:18.133Z.
Quote observation: 2026-10-06T18:18:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c8d7801cb5d69976804150322740a3f9972799eb944d256c77d6faa31d53dc8f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-07-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $35.69M | N/A | N/A | N/A | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.51M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.57M | N/A | 15.63% | 9.19% | 7.93% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.50M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $37.89M | 5.18% | 3.36% | 3.05% | 3.05% |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.48M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2022-07-29 | 0.01% |
| 2022-07-28 | 0.01% |
| 2022-07-27 | 0.01% |
| 2022-07-26 | 0.01% |
| 2022-07-25 | 0.01% |
| 2022-07-22 | 0.01% |
| 2022-07-21 | 0.01% |
| 2022-07-20 | 0.01% |
| 2022-07-19 | 0.01% |
| 2022-07-18 | 0.01% |
| 2022-07-15 | 0.01% |
| 2022-07-14 | 0.01% |
| 2022-07-13 | 0.01% |
| 2022-07-12 | 0.01% |
| 2022-07-11 | 0.01% |
| 2022-07-08 | 0.01% |
| 2022-07-07 | 0.01% |
| 2022-07-06 | 0.01% |
| 2022-07-05 | 0.01% |
| 2022-07-01 | 0.01% |
| 2022-06-30 | 0.01% |
| 2022-06-29 | 0.01% |
| 2022-06-28 | 0.01% |
| 2022-06-27 | 0.01% |
| 2022-06-24 | 0.01% |
| 2022-06-23 | 0.01% |
| 2022-06-22 | 0.01% |
| 2022-06-21 | 0.01% |
| 2022-06-17 | 0.01% |
| 2022-06-16 | 0.01% |
| 2022-06-15 | 0.01% |
| 2022-06-14 | 0.01% |
| 2022-06-13 | 0.01% |
| 2022-06-10 | 0.01% |
| 2022-06-09 | 0.01% |
| 2022-06-08 | 0.01% |
| 2022-06-07 | 0.01% |
| 2022-06-06 | 0.01% |
| 2022-06-03 | 0.01% |
| 2022-06-02 | 0.01% |
| 2022-06-01 | 0.01% |
| 2022-05-31 | 0.01% |
| 2022-05-27 | 0.01% |
| 2022-05-26 | 0.01% |
| 2022-05-25 | 0.01% |
| 2022-05-24 | 0.01% |
| 2022-05-23 | 0.01% |
| 2022-05-20 | 0.01% |
| 2022-05-19 | 0.01% |
| 2022-05-18 | 0.01% |
| 2022-05-17 | 0.01% |
| 2022-05-16 | 0.01% |
| 2022-05-13 | 0.01% |
| 2022-05-12 | 0.01% |
| 2022-05-11 | 0.01% |
| 2022-05-10 | 0.01% |
| 2022-05-09 | 0.01% |
| 2022-05-06 | 0.01% |
| 2022-05-05 | 0.01% |
| 2022-05-04 | 0.01% |
| 2022-05-03 | 0.01% |
| 2022-05-02 | 0.01% |
| 2022-04-29 | 0.01% |
